Trial Profile
A Multi-center, Randomized, Double-blind, Active Control Phase II Study to Investigate Multiple Dosage and Treatments of Magnesium Isoglycyrrhizinate Injection to Cure the Acute Drug-induced Liver Injury
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2016
Price :
$35
*
At a glance
- Drugs Isoglycyrrhizinate (Primary) ; Tiopronin
- Indications Liver injury
- Focus Therapeutic Use
- Sponsors Chia Tai Tianqing Pharmaceutical Group
- 15 Apr 2016 New trial record